In a move that further strengthens Merz Aesthetics’ foothold in aesthetic medicine, the german specialty health care company has acquired Anteis S.A.
Merz Pharmaceuticals has distributed dermal fillers developed by Anteis under the Belotero® brand name since 2005. Anteis has also developed several wrinkle-filling gels, resorbable implants, and cutaneous rehydration gels, including such lines as Esthélis, Fortélis, Mesolis, and Modélis as well as the Jolidermis range and the Anteis Injection Syste, which are available in more than 90 countries in five continents. These products will now be part of the growing Merz Aesthetic portfolio.
Merz recently acquired Neocutis S.A., which specializes in the development of dermocosmetic pre- and post-treatments for aesthetic procedures.
Read more about Merz’ ascent in our exclusive intreview with Jim Hartman, vice president and head, US aesthetics and OTC, at Merz here.